Clinical Trial Details
— Status: Active, not recruiting
Administrative data
| NCT number |
NCT00710723 |
| Other study ID # |
dwille1 |
| Secondary ID |
|
| Status |
Active, not recruiting |
| Phase |
N/A
|
| First received |
January 4, 2008 |
| Last updated |
July 3, 2008 |
| Start date |
October 2005 |
| Est. completion date |
December 2008 |
Study information
| Verified date |
January 2008 |
| Source |
University Hospital, Gasthuisberg |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
Belgium: The Federal Public Service (FPS) Health, Food Chain Safety and Environment |
| Study type |
Interventional
|
Clinical Trial Summary
In assisted reproduction technology (ART), cryopreservation of embryos maximizes the
potential of IVF cycles. Currently different cryopreservation methods are used, the
conventional slow freezing method and vitrification. There is, therefore an immediate need
to assess which cryopreservation technique is preferential in human IVF. In this prospective
randomised study conventional slow freezing and vitrification, using the Hemi-straw carrier
system, of human day 3 embryos were compared.
Description:
1. Background
Although there are studies that reported successful pregnancies after transfer of
vitrified cleavage stage embryos, most of the studies focused on the vitrification of
oocytes and blastocysts. As far as we know, there is only one report of a randomised
prospective study were both common freezing methods -conventional slow freezing and
vitrification (making use of the nylon loop system with 40% ethylene glycol), were
compared for day 3 embryos (Rama Raju, Haranath et al., 2005). They report an
implantation and pregnancy rate (14,9% and 35,0% respectively) with vitrification,
which is significantly higher than the rates with the slow freezing protocol (4,2% and
17,4% respectively). There is still need to more randomised studies which compares both
freezing methods for cleavage stage embryos .
There is evidence in literature that the vitrification method used at LUFc (hemi-straw)
is superior to the method used in the randomised trial of Rama Raju. Liebermann and
Tucker compared both the hemi-straw and cryoloop system for vitrification of day 3
embryos derived from abnormally fertilized zygotes (Liebermann and Tucker, 2002). They
found no statistical difference (p=0.07) in the survival rate, but the development
after 24 hours was statistically better (p =0.002) using hemi-straws. Based on this
study we would even expect better results than the study of Rama Raju.
To further refine the effect of cryopreservation of cleavage stage embryos using the
hemi-straw system on developmental and implantation potential, the effectiveness of
vitrification (20% EG and 20% DMSO) was compared with slow freezing.
2. Materials and methods
- Patients In this prospective study all patients underwent IVF or ICSI between are
included. Fresh embryo transfer was carried out on day 3 after insemination. All
surplus embryos who reached at least the 6 cell stage on day 3 and had less than
20% fragmentation were considered for cryopreservation using either vitrification
or slow freezing.
- Randomisation All embryos will be cryopreserved by one of the two methods.
Randomisation will take place at day 3 after insemination. For practical reasons,
all embryos frozen on the same day will be randomly assigned to the same freezing
method.
- Results from retrospective data analysis Vitrification has been used as a standard
cryopreservation method at the LUFc since September 2004. So both slow freezing
and vitrification had been used for cryopreservation of day 3 embryos. The method
used depends on workload… so there was no randomisation. After a retrospective
analysis of these data (124 cycles 43 in the slow group and 81 in the
vitrification group), we noticed a significant increase in the survival of the
embryos after vitrification (81.2% in the vitrification group versus 45.8% in the
slow group; p<0.0001). There was no significant difference in pregnancy rate
between both groups (19.8% in the vitrification versus 30.2% in slow group; p=NS).
So far we saw a remarkable difference in survival immediately or 24h after thawing, but
a clear difference in the implantation rate has not been discovered yet, therefore we
would like to start a randomised trial to proof a significant difference at the
implantation or pregnancy level.
- Vitrification of human embryos Our method was based on the procedure described by
Vanderzwalmen et al 2000 (Vanderzwalmen, Bertin et al., 2000). First the embryos
were equilibrated (PBS with 17% HSA ) for 2 min at room temperature. They were
then transferred to the first vitrification solution (PBS + 14% HSA + 10% DMSO +
10% ethylene glycol) for 2 min at RT followed by 30 sec in the second
vitrification solution (PBS + 12% HSA + 20 % DMSO + 20% ethylene glycol + ficoll +
sucrose). Finally the embryos were loaded as quickly as possible on the Hemi-straw
in a droplet of approximately 3 µl and immersed directly in liquid nitrogen.
Afterwards the hemi-straw was inserted in the CBS-straw.
- Thawing after vitrification The hemi-straw holding exactly one embryo was pulled
out of the CBS straw and immediately immersed into 3 ml of the first thawing
solution (PBS with 20% HSA) for 3 min at 36°C. Afterwards the embryo was
consecutively exposed for 2 min to the 3 other thawing solutions (0.5M sucrose,
0.25M sucrose and 0.125M sucrose respectively). The embryos were washed thoroughly
and incubated overnight in COOK blastocyst medium. Embryos are considered as
'survived' if at least 50% of the blastomeres survived the vitrification
procedure.
- Slow freezing and thawing procedure For the slow freezing and thawing procedure we
used the HEPES-buffered commercial freezing medium of Cook (K-SICS 5000) with
propandiol and sucrose as cryoprotectants.
3. Statistical analysis and power calculation
Based on literature (Rama Raju et al 2005) we expect a 10 % higher implantation rate in the
vitrification group (25%) versus the slow freezing group (15%)(Rama Raju, Haranath et al.,
2005). To proof a significant difference at the implantation or pregnancy level with α=0,05
and a power (β) of 0,80. Therefore we would need 270 embryos transferred in each group.
